Impact of matrix metalloproteinase-1 gene variations on risk of acute coronary syndrome

Coronary Artery Disease

Volumn 19, Issue 4, 2008, Pages 227-230

  Han, Yaling ^a   Wu, Zefeng ^a   Zhang, Xiaolin ^a   Yan, Chenghui ^a   Xi, Suya ^a   Yang, Yong ^a   Pei, Fang ^a   Kang, Jian ^a  

^a SHENYANG NORTHERN HOSPITAL   (China)

Author keywords

Acute coronary syndrome; Chinese; Coronary heart disease; Haplotype; Matrix metalloproteinase 1; Polymorphism; Risk factor; Vulnerable plaque

Indexed keywords

GENOMIC DNA; INTERSTITIAL COLLAGENASE;

ACUTE CORONARY SYNDROME; ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; AGED; ASIAN; CHINA; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE CORONARY SYNDROME; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS);

EID: 54749093651     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282f9d3d8     Document Type: Article

References (22)

1. Ho PM, Luther SA, Masoudi FA, Gupta I, Lowy E, Maynard C, et al. Inpatient and follow-up cardiology care and mortality for acute coronary syndrome patients in the Veterans Health Administration. Am Heart J 2007; 154: 489-494.
2. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006; 333:1091.
3. Scott IA, Derhy PH, O'Kane D, Lindsay KA, Atherton JJ, Jones MA. Discordance between level of risk and intensity of evidence-based treatment in patients with acute coronary syndromes. Med J Aust 2007; 187: 153-159.
4. Masoudi FA, Foody JM, Havranek EP, Wang Y, Radford MJ, Allman RM. Trends in acute myocardial infarction in 4 US states between 1992 and 2001: clinical characteristics, quality of care, and outcomes. Circulation 2006; 114:2806-2814.
5. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005; 111:3481-3488.
6. Kong YZ, Huang XR, Ouyang X, Tan JJ, Fingerle-Rowson G, Bacher M. Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques. Cardiovasc Res 2005; 65:272-282.
7. Hartung D, Schäfers M, Fujimoto S, Levkau B, Narula N, Kopka K, et al. Targeting of matrix metalloproteinase activation for noninvasive detection of vulnerable atherosclerotic lesions. Eur J Nucl Med Mol Imaging 2007; 34 (Suppl 1):S1-S8.
8. Dabek J, Kulach A, Gasior Z. The role of matrix metalloproteinases in acute coronary syndromes. Eur J Intern Med 2007; 18:463-466.
9. Hamelin BA, Méthot J, Arsenault M, Pilote S, Poirier P, Plante S, Bogaty P. Influence of the menstrual cycle on the timing of acute coronary events in premenopausal women. Am J Med 2003; 114:599-602.
10. Morgan AR, Rerkasem K, Gallagher PJ, Zhang B, Morris GE, Calder PC. Differences in matrix metalloproteinase-1 and matrix metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics. Stroke 2004; 35:1310-1315.
11. Guo A, Wei L, Shi H, Li X, You L. Matrix metalloproteinase-1 and coronary atherosclerotic plaque rupture. Zhong Hua Bing Li Xue Za Zhi 2000; 29:263-266.
12. Higashikata T, Yamagishi M, Higashi T, Nagata I, Iihara K, Miyamoto S, et al. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method. Atherosclerosis 2006; 85 : 165-172.
13. Pearce E, Tregouet DA, Samnegård A, Morgan AR, Cox C, Hamsten A, et al. Haplotype effect of the matrix metalloproteinase-1 gene on risk of myocardial infarction. Circ Res 2005; 97:1070-1076.
14. Me'thot J, Hamelin BA, Bogaty P, Arsenault M, Plante S, Poirier P. Does hormonal status influence the clinical presentation of acute coronary syndromes in women? J Womens Health 2004; 13:695-702.
15. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15:97-98.
16. Poloñski L, Gasior M, Gierlotka M, Kalarus Z, Cieœliñ ski A, Dubiel JS. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol Pol 2007; 65:861-872.
17. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 2004; 292:2096-2104.
18. Fox KA, Poole-Wilson P, Clayton TC, Henderson RA, Shaw TR, Wheatley DJ, et al. 5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet 2005; 366:914-920.
19. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004; 75:353-362.
20. Poulalhon N, Farge D, Roos N, Tacheau C, Neuzillet C, Michel L. Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin, a direct role as an antifibrotic agent? J Biol Chem 2006; 281:33045-33052.
21. Rosemar A, Ivarsson ML, Börjesson L, Holmdahl L. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease. Scand J Gastroenterol 2007; 42: 215-220.
22. Kaden JJ, Dempfle CE, Grobholz R, Fischer CS, Vocke DC, Kiliç R, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005; 14:80-87.